Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Post by somweyungguyon Oct 12, 2016 11:54am

146 Views

Post# 25335254

"clarify their release" - it took 3 NR's to spit out the....

INTERIM DATA

These three releases failed to give the patient population analysed or the ABSOLUTE EFFICACY

Based on the 650 or 600 patient requirement, the interim data suggested an 11% to 12% absolute efficacy

How does that compare to say 5% ?

Sqr

Bullboard Posts

The top 10 Canadian medical stocks